Advertisement

Topics

Eli Lilly to Buy AurKa Pharma and ARMO

06:00 EDT 17 May 2018 | CHEManager

US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A inhibitor, was originally discovered by Lilly, which sold it to TVM Capital Life Science in 2016 after reviewing its clinical pipeline priorities.

Original Article: Eli Lilly to Buy AurKa Pharma and ARMO

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly to Buy AurKa Pharma and ARMO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...